In this solo episode, Sarah takes the “doctor vs brand” framework that went viral on Instagram and runs it as a real-time case study on a real company. The target is Cadense, an adaptive shoe that claims to help with foot drop, toe catch, and neurologic walking difficulties using “variable friction” tech, basically a glide-to-grip outsole design meant to reduce toe snagging while still giving traction during stance and push-off. Sarah breaks down what foot drop is, who this type of device might help, who it might put at risk, and why any rehab-adjacent product should be judged on more than vibe, testimonials, or white-coat authority.

Then she gets into incentives, the part everyone wants to ignore until it’s their wallet. She walks through Cadense’s ambassador, coach, and affiliate pathways, and uses the full checklist to evaluate where Cadense lands on the clinician-led spectrum, including what they disclose well, what they oversimplify, and what they should tighten up if they want to be truly “do no harm” about a product that can literally change someone’s fall risk. Finally, Sarah looks at the actual research (yes, it exists, no, it’s not robust yet), explains what a five-person pilot study can and can’t prove, and lays out the line she personally won’t cross, recommending a product case-by-case versus becoming financially tied to a medical-ish purchase decision.

FREE Barbell Mini Course—SIGN UP

FOLLOW @MovementLogicTutorials on Instagram

Verse Agile Rack, Foldable Home Barbell Rack coupon code MovementLogic50OFF

RESOURCES
Instagram Post: When a Doctor Becomes a Brand
Cadense, Official Website
Cadense Coaches Program, Clinician Partnership
Pilot Study of Cadence, A Novel Shoe for Patients With Foot Drop, Evora et al. 2019
NIH Clinical Trial, Variable Friction Shoe vs AFO (NCT06234124)
Global Wellness Economy Reaches $6.8 Trillion, Global Wellness Institute

121: Do No Harm, But Also Sell Shoes? The Doctor vs Brand Problem